Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
8.15
-0.09 (-1.09%)
Feb 13, 2026, 4:00 PM EST - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $296.72 million as of February 13, 2026. Its market cap has increased by 300.02% in one year.
Market Cap
296.72M
Enterprise Value
459.64M
1-Year Change
300.02%
Ranking
Category
Stock Price
$8.15
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $296.72M, an increase of 540.66%. That is a compound annual growth rate of 31.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 296.72M | 29.78% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 320.27M |
| Aldeyra Therapeutics | 315.85M |
| Century Therapeutics | 314.38M |
| Foghorn Therapeutics | 308.14M |
| Candel Therapeutics | 307.43M |
| Cybin | 295.43M |
| X4 Pharmaceuticals | 294.66M |
| XOMA Royalty | 291.87M |